Medicare Enrolled
Dr. Mayank Mathur, M.D.
Neurology · Lumberton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mathur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mathur?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mathur
Dr. Mayank Mathur is a neurology specialist in Lumberton, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mathur performed 1,046 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mathur received a total of $9,458 from 78 pharmaceutical and/or device companies across 638 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mathur is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 36% volume in NJ
$9,458 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,046
Medicare services
Top 36% in NJ for neurology
Not available
Unique patients (not deduplicated)
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
388 | $99 | $284 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
212 | $152 | $588 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
114 | $87 | $315 |
| New patient office visit, complex (60-74 min) | 99 | $165 | $483 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
79 | $146 | $430 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $140 | $395 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $141 | $365 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
29 | $155 | $645 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $67 | $164 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
23 | $183 | $775 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,458
Total received (2018-2024)
Avg $1,351/year across 7 years
Top 25% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
638
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,703
2023
$1,647
2022
$1,470
2021
$1,073
2020
$430
2019
$1,694
2018
$1,441
Payments by company (2024)
ABBVIE INC.
$342
PFIZER INC.
$221
Lilly USA, LLC
$175
UCB, Inc.
$159
Teva Pharmaceuticals USA, Inc.
$79
SCILEX PHARMACEUTICALS INC.
$76
ARGENX US, INC.
$75
Abbott Laboratories
$70
CSL Behring
$61
Alexion Pharmaceuticals, Inc.
$61
EMD Serono, Inc.
$56
Azurity Pharmaceuticals, Inc.
$53
Vanda Pharmaceuticals Inc.
$34
Neurelis, Inc.
$32
Celgene Corporation
$29
Merz Pharmaceuticals, LLC
$26
Blue Earth Diagnostics Limited
$21
Biogen, Inc.
$16
SK Life Science, Inc.
$16
MDD US Operations, LLC
$16
Amgen Inc.
$15
Currax Pharmaceuticals LLC
$15
Aucta Pharmaceuticals, Inc.
$14
Acorda Therapeutics, Inc
$14
ACADIA Pharmaceuticals Inc
$14
CATALYST PHARMACEUTICALS, INC.
$13
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,019
ABBVIE INC.
$755
UCB, Inc.
$645
Teva Pharmaceuticals USA, Inc.
$538
EMD Serono, Inc.
$436
Lilly USA, LLC
$413
Alexion Pharmaceuticals, Inc.
$374
PFIZER INC.
$352
Avanir Pharmaceuticals, Inc.
$290
Novartis Pharmaceuticals Corporation
$240
Sunovion Pharmaceuticals Inc.
$231
Genentech USA, Inc.
$201
ARGENX US, INC.
$197
Abbott Laboratories
$189
Celgene Corporation
$182
Biohaven Pharmaceuticals, Inc.
$147
Validus Pharmaceuticals LLC
$142
Allergan, Inc.
$131
Acorda Therapeutics, Inc
$127
Adamas Pharmaceuticals, Inc.
$126
GENZYME CORPORATION
$124
Avion Pharmaceuticals
$124
ACADIA Pharmaceuticals Inc
$123
Biohaven Pharmaceutical Holding Company Ltd.
$117
Amgen Inc.
$116
W. L. Gore & Associates, Inc.
$116
Kyowa Kirin, Inc.
$113
CSL Behring
$89
SK Life Science, Inc.
$88
EISAI INC.
$86
AbbVie, Inc.
$80
Neurocrine Biosciences, Inc.
$79
Sumitomo Pharma America, Inc.
$78
SCILEX PHARMACEUTICALS INC.
$76
Azurity Pharmaceuticals, Inc.
$73
Boston Scientific Corporation
$65
AbbVie Inc.
$64
Neurelis, Inc.
$60
GE HealthCare
$60
Medtronic, Inc.
$51
Janssen Pharmaceuticals, Inc
$48
Supernus Pharmaceuticals, Inc.
$47
Scilex Pharmaceuticals Inc.
$47
Mallinckrodt Enterprises LLC
$43
Eisai Inc.
$42
MDD US Operations, LLC
$42
Banner Life Sciences, LLC
$41
GE HEALTHCARE
$38
Mallinckrodt Hospital Products Inc.
$37
Lundbeck LLC
$34
Vanda Pharmaceuticals Inc.
$34
Jazz Pharmaceuticals Inc.
$30
E.R. Squibb & Sons, L.L.C.
$30
Grifols USA, LLC
$28
Akcea Therapeutics, Inc.
$27
Merz Pharmaceuticals, LLC
$26
Zyla Life Sciences
$25
Blue Earth Diagnostics Limited
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
ANI Pharmaceuticals, Inc.
$19
Medtronic USA, Inc.
$18
IMPEL PHARMACEUTICALS INC.
$17
UPSHER-SMITH LABORATORIES LLC
$16
BOSTON SCIENTIFIC CORPORATION
$15
AMAG Pharmaceuticals, Inc.
$15
Exeltis, USA Inc.
$15
Promius Pharma LLC
$15
Allergan Inc.
$15
Currax Pharmaceuticals LLC
$15
Octapharma USA, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Collegium Pharmaceutical, Inc.
$14
Aucta Pharmaceuticals, Inc.
$14
Vertical Pharmaceuticals, LLC
$14
Horizon Therapeutics plc
$14
CATALYST PHARMACEUTICALS, INC.
$13
PORTOLA PHARMACEUTICALS, INC.
$12
Impax Laboratories, Inc.
$12
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BEVYXXA · BOTOX · BRILINTA · Betaseron · Briviact · CARDIOFORM Septal Occluder · COPAXONE · DALVANCE · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Equetro · FERAHEME · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · General - DBS · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · LEMTRADA · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONZETRA XSAIL · Ongentys · PANZYGA · PERCEPT PC BRAINSENSE · PLEGRIDY · POMPE - DISEASE · PONVORY · POSLUMA · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RELEXXII · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · Xembify · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
435
County median income
$105,271
Nearest hospital to ZIP centroid (approximate)
VIRTUA MOUNT HOLLY HOSPITAL
3.9 mi
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mathur is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mathur experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mathur performed 388 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mathur receive payments from pharmaceutical companies?
Yes. Dr. Mathur received a total of $9,458 from 78 companies across 638 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mathur's costs compare to other neurologists in Lumberton?
Dr. Mathur's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mathur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Lumberton
Browse neurologists in Lumberton ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology